Luspatercept in Transfusion‐Dependent β‐Thalassemia: The Benefit Is Real, and So Are the Risks

Authors

Khaled M. Musallam (ORCID: https://orcid.org/0000-0003-3935-903X)

Institutions

Cornell University (US)
Weill Cornell Medicine (US)

Publication Details

Journal: American Journal of Hematology
Published: 2025-06-19
DOI: https://doi.org/10.1002/ajh.27745
Citations: 3
Primary Topic: Hemoglobinopathies and Related Disorders
Type: article
Field-Weighted Citation Impact: 4.88

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Luspatercept in Transfusion‐Dependent β‐Thalassemia: The Benefit Is Real, and So Are the Risks

Khaled M. Musallam

Jun 19, 2025

3 citations

American Journal of Hematology

Hemoglobinopathies and Related Disorders

4.88

article

Luspatercept in Transfusion‐Dependent β‐Thalassemia: The Benefit Is Real, and So Are the Risks

Khaled M. Musallam

June 19, 2025article en

3 citations

Abstract

No abstract available for this paper.

American Journal of HematologyVol. 100(9)

Cornell University (US), Weill Cornell Medicine (US)

Openalex Percentile: Top 5%

Hemoglobinopathies and Related Disorders

4.88

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Luspatercept in Transfusion‐Dependent β‐Thalassemia: The Benefit Is Real, and So Are the Risks — Khaled M. Musallam · American Journal of Hematology (2025) | TGRS Research Map | TGRS